At a glance
ClinicalIndex Comparison RecordN/ACompleted· 120 enrolled
Drug / intervention
GA-arm, remifentanil +1 moredrug
Likely dose
RA-arm 15 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
General Versus Intrathecal Anaesthesia for Patients Undergoing Elective Total Hip Arthroplasty
In Brief
A clinical study evaluating GA-arm, remifentanil and RA-arm for Osteoarthritis. Completed, enrolled 120 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether general anaesthesia or regional anaesthesia is best for patients undergoing Total Hip Arthroplasty.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis
CountriesSweden
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 2012
Enrollment StartJan 2013
Primary CompletionFeb 2014
Study CompletionJun 2014
TodayJul 2026
First PostedNov 27, 2012
Enrollment StartJan 1, 2013
Primary CompletionFeb 1, 2014
Study CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 13.6 years ago
Interventions
GA-arm, remifentanildrug
Remifentanil and propofol will be delivered intravenously via TCI pumps according to the "Marsh" and "Minto" algorithm
RA-armdrug
Intrathecal (i.e. spinal) anesthesia with isobaric bupivacaine 15 mg administered intrathecally at L4-L5.